Patent · US Active

Anti-TIGIT antibodies

US11439705B2 · kind B2 · utility

1Cited by

10References

15Claims

0Family size

Assignee

iTeos Belgium SA · BE

Inventors

Anthony B. Cooper · South San Francisco, US
Christophe Queva · Bainbridge Island, US
Sofie Denies · Gosselies, BE
Catherine Hoofd · Gosselies, BE
Julia Cuende · Gosselies, BE
Gregory Driessens · Ottignies, BE
Florence Lambolez · Gosselies, BE

Key dates

Filing date	May 15, 2019
Grant date	Sep 13, 2022
Priority date	—
Expiry date	May 15, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.